Therapeutic Asset Ratings
625 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ibrutinib
Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center
P2
B
(63)
ALECTINIB
Anaplastic Large Cell Lymphoma
Memorial Sloan Kettering Cancer Center
P2/3
B
(63)
Romidepsin
Bone Marrow Failure
Memorial Sloan Kettering Cancer Center
P2/3
B
(63)
FLUOROURACILUM
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P3
B
(62)
Clofarabine
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(62)
Cyclophosphamide
Beta Thalassemia
Memorial Sloan Kettering Cancer Center
P2
B
(62)
Tislelizumab
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P2
B
(62)
PREDNISONE TABLETS
Sickle Cell Disease
Memorial Sloan Kettering Cancer Center
P3
B
(61)
Calcium folinate pentahydrate
CNS Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(61)
FUROSEMIDE
AML
Memorial Sloan Kettering Cancer Center
P2
B
(61)
Monomethyl Fumarate
Bone Marrow Failure
Memorial Sloan Kettering Cancer Center
P2
B
(61)
Thiotepa
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(61)
ROPIVACAINE
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P4
B
(60)
Clofarabine
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P3
B
(60)
NEPENTHE
Hodgkin Disease
Memorial Sloan Kettering Cancer Center
P3
B
(60)
Oxycodone
Hodgkin Disease
Memorial Sloan Kettering Cancer Center
P3
B
(60)
Vinorelbine
Lymphoma
Memorial Sloan Kettering Cancer Center
P3
B
(60)
ag-120
Chondrosarcoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Bms-907351
Translocation Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
cc-5013
Plasmacytoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Cyclophosphamide
Angiosarcoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
CYCLOSPORIN A
Bone Marrow Failure
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Eloxatin
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Epirubicin
Refractory Cancer
Memorial Sloan Kettering Cancer Center
P2
B
(60)
FLUOROURACILUM
Advanced Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Showing 76 to 100 of 625 assets
Previous
Page 4 of 25
Next